Clinical Trial Update: North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 [NA]

View source ↗

Summary

ClinicalTrials.gov update indicates the UNC Chapel Hill genomic evaluation study using next-generation exome sequencing has completed and posted results, spanni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Brain Malformation
• Developmental Delay
• Epilepsy
• Hypotonia
• Inborn Errors of Metabolism
• Intellectual Disability
• Neuromuscular Diseases

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Epilepsy; Seizure, Neuromuscular Diseases | NA | Status: COMPLETED | Results posted: 2025-05-13